Skip to content

Clinical trials

Phase 4 trials in Russia with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 4 Status: Unknown status Country / region: Russia Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20101
20114
20132
20141
20152
20163
20173
20181
20192
20203
20217
20222
20234
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status38

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Meshalkin Research Institute of Pathology of Circulation4
National Medical Research Center for Children's Health, Russian Federation3
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health2
I.M. Sechenov First Moscow State Medical University2
Institute for Atherosclerosis Research, Russia2
Russian Academy of Medical Sciences2
Center for Vascular Pathology, Moscow1
Central Clinical Hospital #1 of LLC Russian Railways1
City Clinical Hospital No.52 of Moscow Healthcare Department1
Clinical Institute of the Brain, Russia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation3
Influenza, Human3
Stroke3
Diabetes Mellitus, Type 22
Hypertension2
Inflammation2
Ischemic Stroke2
Mitral Valve Insufficiency2
Wounds and Injuries2
Acute Coronary Syndrome1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.